Essel Dulaimi

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer

Elizabeth R. Plimack, Roland L. Dunbrack, Timothy Brennan et al. · European Urology · 2015 · 541 citations · Full text

Medicine, Oncology, Urology +13

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Elizabeth R. Plimack, Jean Hoffman‐Censits, Rosalia Viterbo et al. · Journal of Clinical Oncology · 2014 · 281 citations · Full text

Medicine, Oncology, Urology +13

Tumor Cell-Specific <b> <i>BRCA1</i> </b> and <b> <i>RASSF1A</i> </b> Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

Inmaculada Ibañez de Cáceres, Cristina Battagli, Manel Esteller et al. · Cancer Research · 2004 · 275 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

Essel Dulaimi, Jeanne Hillinck, Inmaculada Ibañez de Cáceres et al. · Clinical Cancer Research · 2004 · 233 citations

Medicine, Genetics, Oncology +17

Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel

Essel Dulaimi, Robert G. Uzzo, Richard E. Greenberg et al. · Clinical Cancer Research · 2004 · 185 citations

Medicine, Genetics, Oncology +17